Structure |
Chemical Name |
CAS |
MF |
![(2R,3R)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine](/CAS/20150408/GIF/380499-06-9.gif) |
(2R,3R)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine |
380499-06-9 |
C20H18F7NO2 |
![Adefovir iMpurity](/CAS/20211123/GIF/1875153-79-9.gif) |
Adefovir iMpurity |
1875153-79-9 |
C15H24N5O6P |
![Anastrozole iMpurity](/) |
Anastrozole iMpurity |
|
|
![Anastrozole iMpurity](/) |
Anastrozole iMpurity |
|
|
![LevosiMendan iMpurity](/) |
LevosiMendan iMpurity |
139052-02-1 |
|
![(Z)-3-((2'-(N'-hydroxycarbaMiMidoyl)biphenyl-4-yl)Methyl)-2-oxo-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylic acid](/CAS/20150408/GIF/1174733-90-4.gif) |
(Z)-3-((2'-(N'-hydroxycarbaMiMidoyl)biphenyl-4-yl)Methyl)-2-oxo-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylic acid |
1174733-90-4 |
C10H14N4O6 |
![rac Cinacalcet HCl](/CAS/20211123/GIF/1025064-33-8.gif) |
rac Cinacalcet HCl |
1025064-33-8 |
C22H22F3N |
![Acyclovir IMpurity I](/) |
Acyclovir IMpurity I |
|
|
![AtracuriuM Besylate IMpurity D Iodide (Mixture of DiastereoMers)](/) |
AtracuriuM Besylate IMpurity D Iodide (Mixture of DiastereoMers) |
|
|
![AzithroMycin IMpurity D](/) |
AzithroMycin IMpurity D |
|
|
![AztreonaM IMpurity E](/) |
AztreonaM IMpurity E |
|
|
![Dasatinib IMpurity 1](/) |
Dasatinib IMpurity 1 |
|
|
![Deferasirox IMpurity 1](/) |
Deferasirox IMpurity 1 |
|
|
![Doxycycline Hyclate IMpurity F](/CAS/20180808/GIF/122861-53-4.gif) |
Doxycycline Hyclate IMpurity F |
122861-53-4 |
C23H25NO8 |
![IpratropiuM BroMide IMpurity E](/CAS/20150408/GIF/CB02674528.gif) |
IpratropiuM BroMide IMpurity E |
183626-76-8 |
C19H27NO3 |
![Minoxidil IMpurity D](/CAS/GIF/75105-16-7.gif) |
Minoxidil IMpurity D |
75105-16-7 |
C11H12N4O4S |
![Ribavirin IMp. D (EP)](/) |
Ribavirin IMp. D (EP) |
|
|
![SalMeterol IMpurity C](/CAS/20150408/GIF/CB02675646.gif) |
SalMeterol IMpurity C |
|
C25H37NO4 |
![3-OXO-3,4-DIHYDROPYRAZINE-2-CARBONITRILE](/CAS/GIF/81411-78-1.gif) |
3-OXO-3,4-DIHYDROPYRAZINE-2-CARBONITRILE |
81411-78-1 |
C5H3N3O |
![RP 48497 (Eszopiclone Impurity C)](/CAS/GIF/148891-53-6.gif) |
RP 48497 (Eszopiclone Impurity C) |
148891-53-6 |
C11H7ClN4O |
![3-(1-methyl-1H-indole-3-carbonyl)hexanedioic acid](/CAS/GIF/CB02486875.gif) |
3-(1-methyl-1H-indole-3-carbonyl)hexanedioic acid |
1352491-75-8 |
C16H17NO5 |
![Decladinose Roxithromycin (Roxithromycin Impurity B)](/CAS/GIF/214902-82-6.gif) |
Decladinose Roxithromycin (Roxithromycin Impurity B) |
214902-82-6 |
C33H62N2O12 |
![Unii-o0p4I5851i](/CAS/20180808/GIF/139563-29-4.gif) |
Unii-o0p4I5851i |
139563-29-4 |
C28H37ClN4O2S |
![Amoxicillin Diketopiperazine (Mixture of Diastereomers)](/CAS/GIF/94659-47-9.gif) |
Amoxicillin Diketopiperazine (Mixture of Diastereomers) |
94659-47-9 |
C16H19N3O5S |
![Amoxicillin Diketopiperazine (Mixture of Diastereomers)](/CAS/GIF/94659-47-9.gif) |
Amoxicillin Diketopiperazine (Mixture of Diastereomers) |
94659-47-9 |
C16H19N3O5S |
![Atorvastatin Oxirane Impurity](/CAS/GIF/1246818-88-1.gif) |
Atorvastatin Oxirane Impurity |
1246818-88-1 |
C26H24FNO3 |
![Dehydro Lovastatin](/CAS/GIF/109273-98-5.gif) |
Dehydro Lovastatin |
109273-98-5 |
C24H34O4 |
![(3S)-3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-4,5-dihydro-2-benzoxepin-1(3H)-one](/CAS2/GIF/1100617-38-6.gif) |
(3S)-3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-4,5-dihydro-2-benzoxepin-1(3H)-one |
1100617-38-6 |
C27H20ClNO2 |
![O-Desethyl N-Trityl Candesartan Cilexetil](/CAS/GIF/934495-65-5.gif) |
O-Desethyl N-Trityl Candesartan Cilexetil |
934495-65-5 |
C50H44N6O6 |
![(R)-(+)-Tolvaptan](/CAS/GIF/331947-66-1.gif) |
(R)-(+)-Tolvaptan |
331947-66-1 |
C26H25ClN2O3 |
![(Z)-Cefdinir](/CAS/GIF/178601-88-2.gif) |
(Z)-Cefdinir |
178601-88-2 |
C14H13N5O5S2 |
![Flucloxacillin impurity E](/) |
Flucloxacillin impurity E |
|
|
![4-(4-Piperidyl)-1-butanol](/CAS2/GIF/57614-92-3.gif) |
4-(4-Piperidyl)-1-butanol |
57614-92-3 |
C9H19NO |
![Pitavastatin Methyl Ester](/CAS/GIF/849811-78-5.gif) |
Pitavastatin Methyl Ester |
849811-78-5 |
C26H26FNO4 |
![1-Cyclopropyl-1,4-dihydro-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid](/CAS/GIF/1029364-73-5.gif) |
1-Cyclopropyl-1,4-dihydro-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid |
1029364-73-5 |
C22H27N3O5 |
![3S,5R isoMer, or (3S,5R)-7-[3-(phenylcarbaMoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calciuM salt](/CAS/GIF/887196-25-0.gif) |
3S,5R isoMer, or (3S,5R)-7-[3-(phenylcarbaMoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calciuM salt |
887196-25-0 |
C33H34CaFN2O5+ |
![3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine](/CAS/GIF/1262133-64-1.gif) |
3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine |
1262133-64-1 |
C20H30FN3O9 |
![5-Chlorodescyano CitalopraM Oxalate](/CAS/GIF/64169-46-6.gif) |
5-Chlorodescyano CitalopraM Oxalate |
64169-46-6 |
C21H23ClFNO5 |
![Acyclovir N-Methyl-L-valinate Hydrochloride](/CAS/GIF/1346617-39-7.gif) |
Acyclovir N-Methyl-L-valinate Hydrochloride |
1346617-39-7 |
C14H23ClN6O4 |
![rac N,N-DidesMethyl-N-(4-hydroxyphenethyl)-O-desMethyl Venlafaxine](/CAS/20140608/GIF/CB02544106.gif) |
rac N,N-DidesMethyl-N-(4-hydroxyphenethyl)-O-desMethyl Venlafaxine |
1346601-21-5 |
C22H29NO3 |
![rac-11-Deoxy-8(12)-dehydro Misoprostol](/CAS/GIF/1331639-92-9.gif) |
rac-11-Deoxy-8(12)-dehydro Misoprostol |
1331639-92-9 |
C22H36O4 |
![5-Nitro-1H-iMidazole-1-ethanol](/CAS/GIF/5006-68-8.gif) |
5-Nitro-1H-iMidazole-1-ethanol |
5006-68-8 |
C5H7N3O3 |
![Hydroxy Adapalene](/CAS/GIF/1346599-76-5.gif) |
Hydroxy Adapalene |
1346599-76-5 |
C28H28O4 |
![SulbactaM IMpurity F](/) |
SulbactaM IMpurity F |
|
|
![N-(4-(2-Methyl-1,4,5,6-tetrahydrobenzo[b]iMidazo[4,5-d]azepine-1-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide](/CAS/20150408/GIF/CB02681126.gif) |
N-(4-(2-Methyl-1,4,5,6-tetrahydrobenzo[b]iMidazo[4,5-d]azepine-1-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide |
|
C32H26N4O2 |
![1-(4-Methoxyphenyl)-6-(4-(2-Methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide](/CAS/20150408/GIF/CB02681131.gif) |
1-(4-Methoxyphenyl)-6-(4-(2-Methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide |
2098457-92-0 |
C26H27N5O4 |
![1-(4-Methoxyphenyl)-6-(4-(2-Methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide](/CAS/20150408/GIF/CB02681131.gif) |
1-(4-Methoxyphenyl)-6-(4-(2-Methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide |
2098457-92-0 |
C26H27N5O4 |
![Epalrestat iMpurity](/CAS/20210111/GIF/109801-00-5.gif) |
Epalrestat iMpurity |
109801-00-5 |
C13H18O |
![5-Oxo Pitavastatin](/CAS/GIF/222306-15-2.gif) |
5-Oxo Pitavastatin |
222306-15-2 |
C25H22FNO4 |
![(3R)-2,3-Dihydro-3-(2-propyn-1-ylaMino)-1H-inden-1-one](/CAS/20150408/GIF/1312077-05-6.gif) |
(3R)-2,3-Dihydro-3-(2-propyn-1-ylaMino)-1H-inden-1-one |
1312077-05-6 |
C12H11NO |
![1-[[2'-(AMinoiMinoMethyl)[1,1'-biphenyl]-4-yl]Methyl]-2-ethoxy-1H-benziMidazole-7-carboxylic Acid](/CAS/20150408/GIF/1442400-65-8.gif) |
1-[[2'-(AMinoiMinoMethyl)[1,1'-biphenyl]-4-yl]Methyl]-2-ethoxy-1H-benziMidazole-7-carboxylic Acid |
1442400-65-8 |
C24H22N4O3 |
![2-Hydroxy Cephalexin](/CAS/GIF/215172-75-1.gif) |
2-Hydroxy Cephalexin |
215172-75-1 |
C16H17N3O5S |
![3-(9H-Carbazol-4-yloxy)-1,2-propanediol](/CAS/20150408/GIF/123119-89-1.gif) |
3-(9H-Carbazol-4-yloxy)-1,2-propanediol |
123119-89-1 |
C15H15NO3 |
![4-(2-Methylpropoxy)-1,3-benzenedicarbothioaMide](/CAS/20150408/GIF/1330632-46-6.gif) |
4-(2-Methylpropoxy)-1,3-benzenedicarbothioaMide |
1330632-46-6 |
C12H16N2OS2 |
![p-Methylcinnamic acid ethyl ester](/CAS/GIF/24393-49-5.gif) |
p-Methylcinnamic acid ethyl ester |
24393-49-5 |
C12H14O2 |
![3-[(2-Hydroxyethyl)amino]propiononitrile](/CAS/GIF/CB02346430.gif) |
3-[(2-Hydroxyethyl)amino]propiononitrile |
33759-44-3 |
C5H10N2O |
![N-(Ethylamino) Fluvoxamine](/CAS/GIF/1217262-11-7.gif) |
N-(Ethylamino) Fluvoxamine
|
1217262-11-7 |
C17H26F3N3O2 |
![Iso Ribavirin (Ribavirin Impurity G)](/CAS/GIF/39030-43-8.gif) |
Iso Ribavirin (Ribavirin Impurity G) |
39030-43-8 |
C8H12N4O5 |
![Iohexol related Compound I](/) |
Iohexol related Compound I |
|
|
![2,2'-Methylene Bis[Ranitidine]](/CAS/GIF/207592-21-0.gif) |
2,2'-Methylene Bis[Ranitidine] |
207592-21-0 |
C27H44N8O6S2 |
![ChloroMethyl Propyl Carbonate](/CAS/GIF/35273-90-6.gif) |
ChloroMethyl Propyl Carbonate |
35273-90-6 |
C5H9ClO3 |
![Bisacodyl Related Compound B (20 mg) (2,4'-(Pyridin-2-ylmethylene)diphenol)](/CAS/GIF/16985-05-0.gif) |
Bisacodyl Related Compound B (20 mg) (2,4'-(Pyridin-2-ylmethylene)diphenol) |
16985-05-0 |
C18H15NO2 |
![Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride)](/CAS/20211123/GIF/4504-96-5.gif) |
Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) |
4504-96-5 |
C18H20ClNO |
![Imiquimod Related Compound B (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline 5-oxide)](/CAS/20150408/GIF/99010-63-6.gif) |
Imiquimod Related Compound B (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline 5-oxide) |
99010-63-6 |
C14H15N3O |
![Ioversol Related Compound B (50 mg) (N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2,4,6-triiodoisophthalamide)](/CAS/20180808/GIF/104517-96-6.gif) |
Ioversol Related Compound B (50 mg) (N,N'-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2,4,6-triiodoisophthalamide) |
104517-96-6 |
C18H24I3N3O9 |
![Edoxaban Impurity 12 (1R,2R,4S)](/CAS/20150408/GIF/500572-10-1.gif) |
Edoxaban Impurity 12 (1R,2R,4S) |
500572-10-1 |
C24H30ClN7O4S |
![paroxetine Mesylate](/CAS/GIF/217797-14-3.gif) |
paroxetine Mesylate |
217797-14-3 |
C20H24FNO6S |
![Linagliptin Impurity L](/) |
Linagliptin Impurity L |
|
|
![Linagliptin Impurity S](/CAS/20180808/GIF/668273-74-3.gif) |
Linagliptin Impurity S |
668273-74-3 |
C30H36N8O4 |
![(R)-2-((6-(3-aminopiperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile](/CAS/20180629/GIF/CB03042203.gif) |
(R)-2-((6-(3-aminopiperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile |
|
C17H18FN5O2 |
![Olaparib impurity 1](/CAS/20180629/GIF/763113-06-0.gif) |
Olaparib impurity 1 |
763113-06-0 |
C24H24N4O3 |
![4-Quinazolinamine,N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)-,hydrochloride(1:1)](/CAS/20180808/GIF/1624294-38-7.gif) |
4-Quinazolinamine,N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)-,hydrochloride(1:1) |
1624294-38-7 |
C22H26ClN3O4 |
![4-Oxiranylmethoxy-benzaldehyde](/CAS/20180629/GIF/14697-49-5.gif) |
4-Oxiranylmethoxy-benzaldehyde |
14697-49-5 |
C10H10O3 |
![Alogliptin Related Compound 24](/CAS/20200515/GIF/1430222-06-2.gif) |
Alogliptin Related Compound 24 |
1430222-06-2 |
C14H12ClN3O2 |
![Apremilast Impurity 1](/) |
Apremilast Impurity 1 |
|
|
![Etoricoxib Impurity 15](/CAS/20180906/GIF/73312-69-3.gif) |
Etoricoxib Impurity 15 |
73312-69-3 |
C5H8ClNO |
![Ibrutinib Impurity 1](/) |
Ibrutinib Impurity 1 |
|
|
![Mirabegron Impurity 13](/) |
Mirabegron Impurity 13 |
|
|
![Riociguat Impurtiy 4](/) |
Riociguat Impurtiy 4 |
|
|
![2,3-Dehydrosilybin B](/CAS/20200611/GIF/142796-24-5.gif) |
2,3-Dehydrosilybin B |
142796-24-5 |
C25H20O10 |
![Cabozantinib Impurity](/CAS/20210111/GIF/1355031-15-0.gif) |
Cabozantinib Impurity |
1355031-15-0 |
C16H14N2O3 |
![Canagliflozin open-ring impurity](/) |
Canagliflozin open-ring impurity |
|
|
![Dapoxetine Impurity E](/) |
Dapoxetine Impurity E |
|
|
![Ilaprazole Impurity](/CAS/20210111/GIF/1018229-53-2.gif) |
Ilaprazole Impurity |
1018229-53-2 |
C11H9N3O |
![Linagliptin Impurity X](/) |
Linagliptin Impurity X |
|
|
![Norfloxacin Imp.(EP)](/CAS/20200611/GIF/1911573-08-4.gif) |
Norfloxacin Imp.(EP) |
1911573-08-4 |
C34H52FN3O4 |
![Rocuronium Bromide Impurity](/CAS/20211123/GIF/13492-57-4.gif) |
Rocuronium Bromide Impurity |
13492-57-4 |
C27H44N2O4 |
![Ruxolitinib Impurity](/) |
Ruxolitinib Impurity |
|
|
![Roxithromycin h](/) |
Roxithromycin h |
|
|
![Ixazomib Impurity 2](/) |
Ixazomib Impurity 2 |
|
|
![sildenafil impurity I](/CAS/20180629/GIF/CB03054710.gif) |
sildenafil impurity I |
|
C22H30N6O4S |
![2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-4-ylmethyl)phenyl]-2-methyl-propaneni](/CAS/GIF/120511-92-4.gif) |
2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-4-ylmethyl)phenyl]-2-methyl-propaneni |
120511-92-4 |
C17H19N5 |
![2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-4-ylmethyl)phenyl]-2-methyl-propaneni](/CAS/GIF/120511-92-4.gif) |
2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-4-ylmethyl)phenyl]-2-methyl-propaneni |
120511-92-4 |
C17H19N5 |
![4-(benzyloxy)-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid](/CAS/20180629/GIF/942195-83-7.gif) |
4-(benzyloxy)-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid |
942195-83-7 |
C16H14N2O3 |
![Tofacitinib Impurity G](/) |
Tofacitinib Impurity G |
|
|
![Ceftaroline Fosamil Impurity 6](/CAS/20211123/GIF/953037-71-3.gif) |
Ceftaroline Fosamil Impurity 6 |
953037-71-3 |
C22H20N8O5S4 |
![Zolmitriptan Related Compound F](/CAS/20180906/GIF/1350928-05-0.gif) |
Zolmitriptan Related Compound F |
1350928-05-0 |
C38H53N7O4 |
![4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butan-1-ol](/CAS/20180629/GIF/913614-15-0.gif) |
4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butan-1-ol |
913614-15-0 |
C16H22N2OS |
![3-((methoxycarbonyl)methyl)-5-methylhexanoic acid](/CAS/20180629/GIF/181289-11-2.gif) |
3-((methoxycarbonyl)methyl)-5-methylhexanoic acid |
181289-11-2 |
C10H18O4 |
![Cyanocobalamin Impurity F](/CAS/20211123/GIF/23208-66-4.gif) |
Cyanocobalamin Impurity F |
23208-66-4 |
C63H85CoN13O15P |